June 19, 2023
AI’s Gatekeepers Aren’t Prepared for What’s Coming
New technologies can change the global balance of power. Nuclear weapons divided the world into haves and have-nots. The Industrial Revolution allowed Europe to race ahead in economic and military power, spurring a wave of colonial expansion. A central question in the artificial intelligence revolution is who will benefit: Who will be able to access this powerful new technology, and who will be left behind?
What is clear is that current state-of-the-art AI models are not safe and no one knows how to reliably make them safe.
Until recently, AI has been a diffuse technology that rapidly proliferates. Open-source AI models are readily available online. The recent shift to large models, such as OpenAI’s ChatGPT, is concentrating power in the hands of large tech companies that can afford the computing hardware needed to train these systems. The balance of global AI power will hinge on whether AI concentrates power in the hands of a few actors, as nuclear weapons did, or proliferates widely, as smartphones have.
Read the full article from Foreign Policy.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko